CTRI/2013/09/004019招募中未知
Immunogenicity and safety of early versus delayed BCG vaccination in moderately preterm infants (31-33 weeks)
niversity College of Medical Sciences and Guru Tegh Bahadur Hospital0 个研究点目标入组 180 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The study shall include preterm AGA babies 31-33 weeks residing <10 km of GTBH and can be contacted whenever required
排除标准
- •Babies of mothers suffering from tuberculosis or receiving antitubercular drugs eclampsia chronic infection severe anaemia known cases HIV positive, Hepatitis B positive Babies having clinical evidence of intrauterine infection undergoing exchange transfusion receiving blood or blood products severe birth asphyxia critically ill babies septicaemia. (3) Babies with congenital anomalies and or clinical suspicion of chromosomal disease
研究者
相似试验
尚未招募
1 期
Safety, preliminary efficacy and immunogenicity of traditional Chinese medicine miRNA hydrogel in the treatment of eczema: a randomized, double-blind, placebo-controlled, dose-increasing clinical studyeczemaITMCTR2000003604Shanghai Skin Disease Hospital
进行中（未招募）
不适用
Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccinePoliomyelitisEUCTR2015-005188-17-Outside-EU/EEASanofi Pasteur SA456
进行中（未招募）
1 期
Safety and Efficacy of Neoadjuvant immunotherapy with Durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (Gemcitabin/Cisplatin or Gemcitabin/Carboplatin) in patients with operable, high-risk, localized urothelial carcinoma of the upper urinary tract.The patient has a histologically-confirmed (ureteroscopic biopsy) or cytologically(urine cytology)-confirmed diagnosis of high-grade urothelial carcinoma of the renal pelvis or ureter. Presence of divergent histologies (i.e. squamous-cell tumor, adenocarcinoma, small cell carcinoma, micropapillary variant) may be acceptable provided that there is an important prevalence (> 90%) of urothelial component.MedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2020-001028-32-FRCHU DE NIMES99
已完成
不适用
Safety, efficacy and immunogenicity of concomitant molecular target drug or cytokine therapy and autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinomaRenal cell carcinomaJPRN-UMIN000014703The University of Tokyo Hospital15
已完成
不适用
Safety, efficacy and immunogenicity of concomitant interferon alpha and autologous tumor lysate-pulsed dendritic cell therapy in patients with advanced renal cell carcinomaRenal cell carcinomaJPRN-UMIN000006646The University of Tokyo Hospital15